vimarsana.com

Latest Breaking News On - Opaleye management - Page 4 : vimarsana.com

Harrow Health, Inc. (NASDAQ:HROW) Expected to Earn Q1 2024 Earnings of ($0.25) Per Share

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley issued their Q1 2024 earnings per share estimates for shares of Harrow Health in a research note issued to investors on Thursday, March 21st. B. Riley analyst M. Mamtani forecasts that the company will post earnings of ($0.25) per share for the […]

Eton-pharmaceuticals-inc
Goldman-sachs-group-inc
Harrow-health
Nasdaq
Nuveen-asset-management
Harrow-health-stock
Barclays-plc
Surface-ophthalmics-inc
Pricet-rowe-associates-inc
News-ratings-for-harrow-health-daily
Vanguard-group-inc

Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Gap Up to $9.69

Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Gap Up to $9.69
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Arcutis-biotherapeutics
Opaleye-management-inc
Jennison-associates
Franklin-resources-inc
Nasdaq
Needham-company
Arcutis-biotherapeutics-inc
Goldman-sachs-group
Vanguard-group-inc
Get-free-report
Point-capital
Opaleye-management

Ocular Therapeutix (OCUL) Announces $325M Private Placement at $7.52/sh

Ocular Therapeutix (OCUL) Announces $325M Private Placement at $7.52/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Ocular-therapeutix-inc
Great-point-partners
Nasdaq
Exchange-commission
Ocular-therapeutix
Venrock-healthcare-capital-partners
Deep-track-capital
Perceptive-advisors
Logos-capital
Surveyor-capital

Ocular Therapeutix, Inc. Announces $325.0 Million Private

BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) Ocular Therapeutix, Inc. (Nasdaq:OCUL) (the “Company”), a biopharmaceutical company committed to.

United-states
Joyce-allaire
Donald-notman
Ocular-therapeutix-inc
Nasdaq
Exchange-commission
Great-point-partners
Venrock-healthcare-capital-partners
Deep-track-capital
Perceptive-advisors
Logos-capital
Surveyor-capital

Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement

Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states
Joyce-allaire
Donald-notman
Ocular-therapeutix-inc
Great-point-partners
Nasdaq
Exchange-commission
Venrock-healthcare-capital-partners
Deep-track-capital
Perceptive-advisors
Logos-capital
Surveyor-capital
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.